Report of the National Cancer Institute and the Eunice Kennedy Shriver National Institute of Child Health and Human Development–sponsored workshop: gynecology and women’s health–benign conditions and cancer

Samimi G, Goli Samimi, Neeraja Sathyamoorthy, Sathyamoorthy N, Candace Tingen, Candace M Tingen, Tingen CM, Mazloomdoost D, Donna Mazloomdoost, Jennie Conroy, Conroy J, Brandy Heckman-Stoddard, Brandy M. Heckman‐Stoddard, Lisa M Halvorson, Halvorson LM
American journal of obstetrics and gynecology · 2020 · vol. 223(6) , pp. 796–808 · doi:10.1016/j.ajog.2020.08.049 · PMID:32835714 · W3080401130
article OA: closed CC0 ⤵ 3 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-06 ⓘ

This workshop report summarizes discussions and findings from the National Cancer Institute and Eunice Kennedy Shriver National Institute of Child Health and Human Development regarding gynecology, women's health, benign conditions, and cancer.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The Division of Cancer Prevention and the Division of Cancer Biology at the National Cancer Institute and the Gynecologic Health and Disease Branch in the National Institute of Child Health and Human Development organized a workshop in April 2019 to explore current insights into the progression of gynecologic cancers from benign conditions. Working groups were formed based on 3 gynecologic disease types: (1) Endometriosis or Endometrial Cancer and Endometrial-Associated Ovarian Cancer, (2) Uterine Fibroids (Leiomyoma) or Leiomyosarcoma, and (3) Adenomyosis or Adenocarcinoma. In this report, we highlight the key questions and current challenges that emerged from the working group discussions and present potential research opportunities that may advance our understanding of the progression of gynecologic benign conditions to cancer.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Genital Diseases, Female Genital Neoplasms, Female Adenocarcinoma Adenocarcinoma Adenocarcinoma Adenocarcinoma Adenocarcinoma Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Carcinoma, Endometrioid Carcinoma, Endometrioid Carcinoma, Endometrioid Carcinoma, Endometrioid Carcinoma, Endometrioid Disease Progression Endometrial Neoplasms Endometrial Neoplasms

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (100)

Cited by (3)

Source provenance

europepmc
last seen: 2026-07-27T06:15:28.040536+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:21:47.975235+00:00
License: CC0 · commercial use OK